SCHEMBL4003566

SCHEMBL4003566

CC(C)S(=O)(=O)c1ccc(N)c(NCC2CCOCC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.47
BRD4 O60885 4/20 0.43
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
LMNA P02545 1/20 0.39
LRRK2 Q5S007 1/20 0.39
HDAC1 Q13547 3/20 0.37
HDAC2 Q92769 3/20 0.37
CNR2 P34972 1/20 0.36
ATM Q13315 1/20 0.36
ATR Q13535 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ALDH3A1 P30838 1/20 0.36
HDAC3 O15379 2/20 0.35
KCNH3 Q9ULD8 1/20 0.35
PTGER4 P35408 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
KDM4E B2RXH2 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4005332 0.91 RORC (0.49) RORCBRD4PTGS1PTGS2LRRK2
SCHEMBL4003748 0.85 RORC (0.46) RORCBRD4PTGS1PTGS2LMNA
SCHEMBL3998455 0.81 MEN1 (0.54) RORCBRD4LMNAALDH1A1MEN1
SCHEMBL3996701 0.81 BRD4 (0.51) RORCBRD4CNR2ALDH1A1ALDH3A1
SCHEMBL3998371 0.77 RORC (0.38) RORCBRD4PTGS1PTGS2LRRK2
SCHEMBL3994829 0.77 ALDH1A1 (0.51) RORCBRD4PTGS1PTGS2LRRK2
SCHEMBL3997147 0.76 RORC (0.48) RORCBRD4PTGS1PTGS2LRRK2
SCHEMBL1700398 0.75 BRD4 (0.48) RORCBRD4PTGS1PTGS2LRRK2
SCHEMBL16035266 0.74 PTGER4 (0.41) HDAC1HDAC2CNR2HDAC3KCNH3
SCHEMBL15067148 0.74 BRD4 (0.51) RORCBRD4CNR2ALDH1A1ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598393-B2 Sulfonyl benzimidazole derivatives PFIZER INC. (US) 2009-10-06 US disclosed
US-20060094750-A1 Sulfonyl benzimidazole derivatives KON-I KANA 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094750-A1 Sulfonyl benzimidazole derivatives TRPV1, CNR2, CNR1 RORC 78/4885BRD4 207/4885PTGS1 596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.